GNH USA

Europe — EMA

Laviola

GNH USA supplies Laviola (Dienogest/Ethinylestradiol), an oral contraceptive for contraception and menstrual regulation. Request a quote for global supply.

Dienogest, Ethinylestradiol

Request sourcing

1
Pack/s

What is Dienogest, Ethinylestradiol?

Dienogest/Ethinylestradiol, the active ingredient in Laviola, is a combined oral contraceptive presented as a tablet for oral use. It works by inhibiting ovulation and altering cervical mucus, thereby preventing unintended pregnancy and may also help regulate menstrual cycles in women of reproductive age.

GNH USA supplies Laviola as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with consistent quality, regulatory compliance and reliable delivery.

What is Dienogest, Ethinylestradiol used for?

Laviola, a combined oral contraceptive, is used within the hormonal contraception family to manage reproductive health conditions. - Contraception: prevention of unintended pregnancy in women of reproductive age. - Menstrual cycle regulation: reduction of irregular bleeding and stabilization of cycle length. - Management of dysmenorrhea: alleviation of menstrual pain associated with primary dysmenorrhea.

What are the side effects of Dienogest, Ethinylestradiol?

Laviola may cause a range of adverse reactions. Patients should be informed of both frequent and less common events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Severe hypertension: sudden increase in blood pressure. - Liver dysfunction: abnormal liver enzyme elevations or jaundice.

What precautions apply to Dienogest, Ethinylestradiol?

Before prescribing Laviola, clinicians should consider several safety aspects. - Assess cardiovascular risk: evaluate personal or family history of thromboembolic events. - Screen smoking status: avoid use in women over 35 who smoke. - Review liver function: contraindicated in severe hepatic impairment. - Consider drug interactions: avoid concomitant use with strong enzyme inducers. - Store at ambient temperature: keep tablets in the original pack, protect from moisture and heat.

What does Dienogest, Ethinylestradiol interact with?

Laviola can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Antifungal azoles (e.g., ketoconazole): can increase hormone levels, raising risk of side effects.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., valproate): may require monitoring of cycle control. - Antihypertensives (e.g., ACE inhibitors): possible alteration of blood pressure control. - Herbal supplements (e.g., St. John’s wort): may diminish contraceptive reliability.

Frequently asked questions

What is Laviola used for?+
Laviola is a combined oral contraceptive containing dienogest and ethinylestradiol. It is prescribed to prevent unintended pregnancy and can also help regulate menstrual cycles and reduce symptoms such as irregular bleeding or painful periods in women of reproductive age.
How does dienogest/ethinylestradiol work in Laviola?+
The ethinylestradiol component suppresses the pituitary release of luteinising hormone, while dienogest blocks ovulation and thickens cervical mucus. Together they prevent the release of an egg and create a hostile environment for sperm, reducing the chance of fertilisation and implantation.
What is the usual dose of Laviola?+
The dosing regimen for Laviola is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the schedule indicated on the prescription label, but the exact regimen should be confirmed with the prescriber.
Is Laviola safe to use during pregnancy or breastfeeding?+
Laviola is intended for use only when pregnancy is not desired. It should not be started during an existing pregnancy, and women who become pregnant while taking it should discontinue use. Safety during breastfeeding has not been fully established, so a healthcare provider should be consulted before use.
How do I order Laviola from GNH USA?+
To order Laviola, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Laviola compare with other combined oral contraceptives?+
Laviola contains the progestogen dienogest, which has a lower androgenic activity compared with some older progestins. This profile may result in fewer androgen‑related side effects such as acne, while providing contraceptive efficacy comparable to other combined oral contraceptives that contain levonorgestrel or desogestrel.
What are the storage requirements for Laviola?+
Laviola tablets should be stored at ambient temperature, below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure they are out of reach of children.
How is Laviola administered?+
Laviola is taken orally, usually once daily at the same time each day. The tablet is swallowed with water and should be taken with or without food as directed by the prescriber.
What are the most serious risks associated with Laviola?+
Serious risks include venous or arterial thromboembolism, severe hypertension, and rare liver disorders. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should discuss these risks with their healthcare provider before starting Laviola.
Who should not use Laviola?+
Laviola is contraindicated in women with known or suspected pregnancy, active or past thromboembolic disease, uncontrolled hypertension, severe liver disease, or known hypersensitivity to any component of the product. It should also be avoided in women over 35 who smoke.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Dienogest, Ethinylestradiol
Route
Oral Use
Manufacturer
Teva Gmbh
Origin
EU

Related products